$Cocrystal Pharma (COCP.US)$ The new compounds in the publication are exclusively licensed and being developed by Cocrystal Pharma for COVID-19. K-State Innovations Partners handles commercial technology licensing for the university. https://www.eurekalert.org/pub_releases/2020-08/ksu-nps080320.p...
Sushi Neko
ID:
70143201
该用户很懒,暂未添加个人简介
关注